Commercial experience across several models
Kevin’s commercial work includes enterprise platform sales, embedded software distribution, connected medical products, diagnostics, payer-supported services, and direct publishing. It spans both creating the product and obtaining the relationships needed for it to reach a user.
That background informs his later clinical technology decisions. Product value, delivery cost, partner obligations, and the operating model remain connected even when the immediate customer is an internal sponsor organization.
Enterprise transactions
At Vitria, Kevin led telecom channel development and platform-integration strategy during the post-IPO scaling period. His career record describes a $3 million strategic partnership with Amdocs for embedded middleware distribution. Earlier telecommunications platform work included RFP response leadership and a $9 million prepaid platform deployment with Optus Australia.
These transaction values are reported in Kevin’s career documents. They demonstrate the scale and nature of commercial responsibility claimed, while original contracts and financial disclosures are not public attachments.
Healthcare models
At Diabetech, Kevin combined product development with partnerships involving LifeScan, telecommunications companies, payers, providers, researchers, and health systems. HealthCordia and Diabetes HouseCall connected technology to care operations and reimbursement. HomeCheck-A1c brought laboratory processing, logistics, and results delivery into a patient-facing service.
His experience includes program evidence and actuarial review supporting payer conversations, plus practical knowledge of access, claims, support, and physician participation. Commercial design therefore extended beyond selling a device or licensing software.
Platform lineage
Kevin’s later career account describes licensing connected-device and cloud technology into a commercial lineage through Telcare and BioTelemetry to Philips Virtual Care Management. The archive presents this as his documented career account. Philips’ 2023 announcement is linked for the later market context, not as independent verification of each transaction in that chain.
No claim of present ownership, ongoing royalties, or responsibility for Philips’ current products is implied.
Direct channels and publishing
MediSelf Press demonstrates direct product packaging, ecommerce, distribution, customer support, fulfillment, and audience development around specialist content. Sugar Surfing combines a clinical collaboration with a published product and a sustained patient community.
Together, the record shows how Kevin links product decisions to a viable way of reaching users, delivering value, and sustaining operations. The experience is relevant to product strategy, partner development, commercial readiness, and operating leadership.
Sources and record basis
- Market contextPhilips · Virtual Care Management announcement, 2023
Describes Philips Virtual Care Management. It illustrates the later market category; it is not, by itself, verification of the full Diabetech licensing chain.
- Published workSugar Surfing · Author and book resource
The patient-education work co-authored by Stephen W. Ponder and Kevin L. McMahon and published by MediSelf Press.
- Current professional workMediSelf Press
Kevin’s publishing imprint and current publishing activity.